首页> 外文期刊>BMC Medical Informatics and Decision Making >Designing concept maps for a precise and objective description of pharmaceutical innovations
【24h】

Designing concept maps for a precise and objective description of pharmaceutical innovations

机译:设计概念图以准确客观地描述药物创新

获取原文
           

摘要

Background When a new drug is launched onto the market, information about the new manufactured product is contained in its monograph and evaluation report published by national drug agencies. Health professionals need to be able to determine rapidly and easily whether the new manufactured product is potentially useful for their practice. There is therefore a need to identify the best way to group together and visualize the main items of information describing the nature and potential impact of the new drug. The objective of this study was to identify these items of information and to bring them together in a model that could serve as the standard for presenting the main features of new manufactured product. Methods We developed a preliminary conceptual model of pharmaceutical innovations, based on the knowledge of the authors. We then refined this model, using a random sample of 40 new manufactured drugs recently approved by the national drug regulatory authorities in France and covering a broad spectrum of innovations and therapeutic areas. Finally, we used another sample of 20 new manufactured drugs to determine whether the model was sufficiently comprehensive. Results The results of our modeling led to three sub models described as conceptual maps representingi) the medical context for use of the new drug (indications, type of effect, therapeutical arsenal for the same indications), ii) the nature of the novelty of the new drug (new molecule, new mechanism of action, new combination, new dosage, etc.), and iii) the impact of the drug in terms of efficacy, safety and ease of use, compared with other drugs with the same indications. Conclusions Our model can help to standardize information about new drugs released onto the market. It is potentially useful to the pharmaceutical industry, medical journals, editors of drug databases and medical software, and national or international drug regulation agencies, as a means of describing the main properties of new pharmaceutical products. It could also used as a guide for the writing of comprehensive and objective texts summarizing the nature and interest of new manufactured product.
机译:背景技术当新药投放市场时,有关新制成品的信息包含在国家药品机构发布的专着和评估报告中。卫生专业人员需要能够快速,轻松地确定新制造的产品是否对他们的实践有用。因此,有必要确定最好的方式来组合在一起并可视化描述新药的性质和潜在影响的主要信息。这项研究的目的是识别这些信息项,并将它们组合成一个模型,该模型可以用作表示新制造产品的主要特征的标准。方法我们基于作者的知识,开发了药物创新的初步概念模型。然后,我们使用法国国家药品监管机构最近批准的40种新制造药物的随机样本对模型进行了完善,该新产品涵盖了广泛的创新和治疗领域。最后,我们使用了另外20种新生产药物的样本来确定模型是否足够全面。结果我们的建模结果导致三个子模型被描述为概念图,代表i)新药使用的医学背景(适应症,作用类型,相同适应症的治疗性武库),ii)新颖性的性质新药物(新分子,新作用机理,新组合,新剂量等),以及iii)与具有相同适应症的其他药物相比,该药物在功效,安全性和易用性方面的影响。结论我们的模型可以帮助标准化有关投放市场的新药的信息。作为描述新药品主要特性的手段,它可能对制药行业,医学期刊,药物数据库和医学软件的编辑以及国家或国际药物监管机构很有用。它也可以用作编写综合性和客观性文本的指南,概述新制造产品的性质和兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号